<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02296333</url>
  </required_header>
  <id_info>
    <org_study_id>03 2014 05</org_study_id>
    <nct_id>NCT02296333</nct_id>
  </id_info>
  <brief_title>Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen</brief_title>
  <acronym>OOEOPAOA</acronym>
  <official_title>Double Blinded Study Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mustafa Kemal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mustafa Kemal University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether the effect of ondansetron on the analgesic
      effect of acetaminophen. Because 5HT3 blockers prevent the analgesic effects of acetaminophen
      and also reduce opioid consumption
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators enrolled 80 American Society of Anesthesiologists Physical Status I-II
      women 18-80 years old scheduled for hysterectomy under general anesthesia over the course of
      a year. The study will be restricted hysterectomies with horizontal abdominal skin incision
      who will be able to operate a patient-controlled analgesia (PCA) device.

      Participating women will be premedicated with 1-2 mg intravenous (IV) midazolam per
      preference of the attending anesthesiologist.

      Anesthesia will be induced with propofol (2 mg/kg IV); intubation will be facilitated by
      rocuronium (0.6 mg/kg IV); and anesthesia will be maintained by sevoflurane in combination
      with nitrous oxide 50% in oxygen. Fentanyl, 2 µg/kg intravenous will be given 3-5 min before
      the surgical incision.

      After endotracheal intubation, all patients' lungs will be mechanically ventilated to
      maintain the end-expiratory carbon dioxide values between 34 and 36 mmHg.

      A Pfannenstiel approach will be used in each woman, and the same surgeon will be conducted
      all operations.

      Randomization will be web-based and out of the control of any investigator. The web system
      will be accessed by the anesthesia resident at the induction. Drugs will be covered by opaque
      plastic to keep the surgical team and anesthesiologists blinded to treatment.

      Both groups patients will be received 1 g acetaminophen in 100 ml saline given every 6 hours
      starting with the skin closure for 24 hours, an amount generally regarded as safe.

        1. Group I patients will be received '8 mg ondansetron hydrochloride'

        2. Group II patients will be received '2 ml saline' Both of them will be applied in a 100
           ml saline bag at the same time with the skin closure.

      After return of spontaneous ventilation and tracheal extubation, patients will be transferred
      to the post anesthesia care unit (PACU).

      Patients were connected to a patient-controlled analgesia (PCA) device and postoperative
      analgesia will be provided using 20-mg intravenous bolus injections of tramadol at a lockout
      interval of 15 min and with a maximum 4-h limit of 150 mg. The PCA device will be
      discontinued when the patient made no demands for the opioid analgesic in the preceding 4-h
      interval or at a maximum of 24 hours after surgery.

        -  heart rate

        -  systolic arterial blood pressures

        -  diastolic arterial blood pressures

        -  mean arterial blood pressures

        -  oxygen saturation

        -  respiratory rate

        -  visual analogue scales while sitting and laying

        -  tramadol consumption

        -  additive analgesics

        -  complications

        -  postoperative nausea and vomiting scores

        -  antiemetic use will be assessed at PACU, 1th. hour, 4th hour, 8th hour, 12th hour, 16th
           hour, 20th hour and 24th hour.

        -  Pain satisfaction scale

        -  ambulation time

        -  first flatus time

        -  oral intake time

        -  Hospital anxiety and depression scale

      When pain scores were VAS ≥5, then as a rescue analgesics 75 mg diclofenac Na intramuscularly
      will be given. If systolic arterial pressure (SAP) will be &lt;90 mmHg or mean arterial pressure
      will be &lt;50 mmHg, 5 mg intravenous ephedrine HCl will be given. If the heart rate will be &lt;50
      beats/minute, 0.5 mg atropine sulfate intravenous will be given. When patients sustained
      nausea or vomiting lasting longer than 5 minutes, metoclopramide (10 mg intravenously) will
      be given.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Visual analogue scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid (tramadol) consumption</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Tramadol consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>Postoperative 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>ondansetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ondansetron iv, 8 mg, skin closure time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>isotonic</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>isotonic 2ml, once, skin closure time</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ondansetron</intervention_name>
    <description>8 mg intravenous in the skin closure</description>
    <arm_group_label>ondansetron</arm_group_label>
    <other_name>Zofran</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>isotonic</intervention_name>
    <description>8 mg intravenous in the skin closure</description>
    <arm_group_label>isotonic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18-80 years old scheduled for hysterectomy

          -  Horizontal or vertical abdominal skin incision

          -  Ability to operate a patient-controlled analgesia (PCA) device

          -  Written informed consent.

        Exclusion Criteria:

          -  Emergency or urgent procedures

          -  Women with pre-existing chronic pain at any site requiring opioid analgesia

          -  Who had a history of significant Axis I psychiatric disease (major depressive
             disorder, bipolar disorder, schizophrenia, etc.)

          -  Significant hepatic (alanine aminotransferase or aspartate aminotransferase &gt;2 times
             normal) or renal (serum creatinine &gt;2 mg/dl) impairment

          -  Allergy to ondansetron or acetaminophen

          -  Were pregnant
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Onur Koyuncu, Ass.prof</last_name>
    <role>Study Chair</role>
    <affiliation>Mustafa Kemal University Medicine Faculty</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mustafa Kemal University Medicine Faculty</name>
      <address>
        <city>Hatay</city>
        <zip>31030</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/20220746</url>
    <description>http://www.ncbi.nlm.nih.gov/pubmed/20220746</description>
  </link>
  <results_reference>
    <citation>Tjølsen A, Lund A, Hole K. Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol. 1991 Feb 7;193(2):193-201.</citation>
    <PMID>1904822</PMID>
  </results_reference>
  <results_reference>
    <citation>Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther. 2006 Apr;79(4):371-8.</citation>
    <PMID>16580905</PMID>
  </results_reference>
  <results_reference>
    <citation>Jokela R, Ahonen J, Seitsonen E, Marjakangas P, Korttila K. The influence of ondansetron on the analgesic effect of acetaminophen after laparoscopic hysterectomy. Clin Pharmacol Ther. 2010 Jun;87(6):672-8. doi: 10.1038/clpt.2009.281. Epub 2010 Mar 10.</citation>
    <PMID>20220746</PMID>
  </results_reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2014</study_first_submitted>
  <study_first_submitted_qc>November 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2014</study_first_posted>
  <last_update_submitted>March 12, 2015</last_update_submitted>
  <last_update_submitted_qc>March 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mustafa Kemal University</investigator_affiliation>
    <investigator_full_name>Onur Koyuncu</investigator_full_name>
    <investigator_title>Assistant Proffesor</investigator_title>
  </responsible_party>
  <keyword>Acetaminophen, ondansetron</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

